News

French antiviral drug is ruled ineffective

BMJ 1994; 309 doi: https://doi.org/10.1136/bmj.309.6948.148 (Published 16 July 1994) Cite this as: BMJ 1994;309:148
  1. A Dorozynski

    French health authorities have declared ineffective an antiviral drug that has been prescribed to hundreds of patients with AIDS over the past six years. The drug, PB-100, was designed by a former researcher at the Pasteur Institute, Mirko Beljanski, and has become increasingly popular with doctors and patients, although its prescription and marketing have never been authorised. A number of patients are still receiving it, and it is far from certain that the so called “Beljanski affair” is over.

    Beljanski, a doctor of biology, joined the Pasteur Institute in 1948, when he was 25, to work under Professor Pierre Lepine, who developed the French polio vaccine. Later he moved to the molecular biology department …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe